New York, NY (PRWEB) December 11, 2009
Boliven Publications, a free scientific abstract and bibliographic information service for Boliven Network Members, now includes nearly 20 million PubMed citations and articles for free use by its members as well as weblinks to related free data in clinical trials, patents, and FDA drug and device data.
“For the first time, scientists, doctors, and IP professionals can quickly and easily link between patent data, PubMed citation data, and clinical trials data, speeding collaboration, open innovation – and eventually the development of life-saving medicines – in the life sciences.” said Thomas Lehrman, Founder and President of Boliven.
Unique features and capabilities of Boliven’s PubMed integration include:
1. Links to Patents, Clinical Trials, Drugs, and Medical Devices Data – Boliven’s PubMed data includes hyperlinks to referenced clinical trials as well as integrated search across patent, drug, and medical device databases.
2. Work Portfolio™ and Innovation Network™ Integration – The scientific authors included in the PubMed dataset can create a Work Portfolio™ of their publications, clinical trials, and patents and expand their Innovation Network™ on Boliven for free by joining.
3. PartnerMatch™ Integration – As members save PubMed abstracts and articles to their Work Portfolio™, Boliven will recommend other scientists and biomedical researchers who have common interests and might make good partners for new research activities.
Boliven has also taken care to include the ability to search by MeSH terms and other features found on PubMed so that the experience users have come to expect at PubMed travels with them when they search PubMed abstracts on Boliven.
Who participates in the Boliven Network?
Over 5,000 leading scientists, doctors, patent attorneys, technology entrepreneurs, executives, and investors participate in the Boliven Network, including those affiliated with the following institutions:
Companies: Apple, Boehringer Ingelheim, Boston Consulting Group, Dell, Dow Chemical, Dr. Reddy's, GE, IBM, Intel, L’Oreal Group, McKinsey, Merck & Co., Microsoft, Novartis, Nvidia, Pfizer, Philips, Procter & Gamble, Rohm and Haas, Sanofi-aventis, Schlumberger, Texas Instruments, United Technologies, W.L. Gore & Associates, among many other research and technology oriented companies.
Universities: CalTech, Columbia, Cornell, Duke, Georgetown, Harvard, Johns Hopkins, MIT, New York University, Northwestern, Oxford, Princeton, Purdue, Stanford, University of Texas (MD Anderson), University of California, University of Illinois, University of Chicago, University of Michigan, University of Pennsylvania, University of Virginia, Yale, among other leading U.S. and foreign research universities.
Government Agencies: European Patent Office (EPO), Korea Intellectual Property Office (KIPO), National Aeronautics and Space Administration (NASA), State Intellectual Property Office of the People’s Republic of China (SIPO), U.S. Department of Commerce, U.S. Department of Defense, U.S. Department of Energy (national laboratories), U.S. Department of Justice, U.S. Department of State, and the U.S. Patent & Trademark Office, among others.
Law Firms: Baker & Mckenzie, Bryan Cave, Darby & Darby, Dechert, DLA Piper, Fish & Richardson, Foley & Lardner, Gibson Dunn & Crutcher, Greenberg Traurig, Jones Day, K&L Gates, Kenyon & Kenyon, Kirkland & Ellis, Mayer Brown, McDermott Will & Emery, Merchant & Gould, Morgan Lewis, Nixon & Vanderhye, Sidley Austin, Townsend and Townsend and Crew, Venable, White & Case, along with many specialty technology and intellectual property law firms.
Founded in 2007, Boliven is an open innovation professional network built on the trusted foundation of over 100 million peer-reviewed and public record documents. Boliven helps users discover and develop new client, partner, and career opportunities through Your Innovation Network™, the professional network users have already built but never knew they had.
The Boliven community includes leading inventors and scientists, IP law partners, technology executives, technology licensing directors and professionals, students and research fellows, and technology venture investors from among the Fortune 100, top 200 law firms, top 25 research universities, and leading technology-focused venture investment firms globally.
For more information, visit http://www.boliven.com
Founder and President